RecruitingNot ApplicableNCT06431360
Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid
Sponsor
Nanjing First Hospital, Nanjing Medical University
Enrollment
80 participants
Start Date
May 14, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Keloid patients were randomized into the experimental and control groups. Experimental group: Strontium-90 (Sr-90) brachytherapy followed by hyperthermia. Control group: Sr-90 brachytherapy alone .
Eligibility
Min Age: 16 YearsMax Age: 75 Years
Inclusion Criteria2
- The patient was clinically diagnosed with keloid, and the keloid area was clean without rupture and exudation；
- Body surface keloid thickness: 2~5mm, diameter ≥10mm.
Exclusion Criteria5
- Women who plan to become pregnant within 3 months or are pregnant or breastfeeding;
- Patients with cicatricial constitution;
- Abnormal coagulation function;
- Patients who have received an adequate dose or course of radiation therapy;
- People with previous immune system diseases, diabetes and other metabolic diseases.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERhyperthermia
hyperthermia (using a heater, 44℃for 15 min)
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06431360
Related Trials
Genetic Analysis of Keloids
NCT016195531 location
Radiotherapy for Keloids
NCT047222631 location
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
NCT063734581 location
A Phase 1c Study Investigating the SAfety and TolErability of a LysyL Oxidase InhibiTor (PXS-6302) in the amElioration of Keloids
ACTRN126250002694371 location
Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars
NCT061389641 location